Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Christopher Armstrong, PhD, OMF Science Liaison

Chris Armstrong, PhD, is most well known for his research using metabolomics to observe biochemical alterations in ME / CFS patients. He began his work in this field at the University of Melbourne, beginning a PhD project to apply metabolomics to study Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) and published his first ME / CFS metabolomics study on blood and urine in 2015.

Since then Chris has set up collaborative efforts to apply metabolomics to immunological experiments on ME / CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research in ME / CFS while looking to extend metabolic capabilities across the field of ME / CFS to help collate different patient groups.

Chris is working with OMF’s communications to translate science for the public while continuing his research as a Visiting Scholar at Stanford University. Chris and his wife have one dog.

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks